CHARLES SCHWAB INVESTMENT MANAGEMENT INC - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 127 filers reported holding G1 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$30,983
-94.8%
21,516
-91.0%
0.00%
Q2 2023$596,626
+8.9%
239,609
+17.2%
0.00%
Q1 2023$547,696
-44.9%
204,364
+11.6%
0.00%
Q4 2022$994,331
-56.0%
183,118
+1.2%
0.00%
-100.0%
Q3 2022$2,260,000
+194.3%
180,891
+16.5%
0.00%
Q2 2022$768,000
-62.1%
155,315
-41.7%
0.00%
-100.0%
Q1 2022$2,025,000
-23.9%
266,345
+2.2%
0.00%0.0%
Q4 2021$2,662,000
-17.4%
260,701
+8.6%
0.00%0.0%
Q3 2021$3,223,000
-38.7%
240,133
+0.1%
0.00%
-50.0%
Q2 2021$5,262,000
-3.6%
239,804
+5.8%
0.00%0.0%
Q1 2021$5,456,000
+50.5%
226,750
+12.5%
0.00%
+100.0%
Q4 2020$3,626,000
+56.2%
201,518
+0.3%
0.00%0.0%
Q3 2020$2,322,000
-52.0%
200,999
+0.7%
0.00%
-50.0%
Q2 2020$4,841,000
+135.6%
199,539
+7.0%
0.00%
+100.0%
Q1 2020$2,055,000
-57.5%
186,458
+2.0%
0.00%
-66.7%
Q4 2019$4,834,000
+18.0%
182,880
+1.7%
0.00%
+50.0%
Q3 2019$4,095,000
-19.8%
179,739
+8.0%
0.00%
-33.3%
Q2 2019$5,103,000
+119.0%
166,430
+18.6%
0.00%
+200.0%
Q1 2019$2,330,000
-9.9%
140,351
+4.0%
0.00%
-50.0%
Q4 2018$2,585,000
-59.8%
134,960
+9.8%
0.00%
-50.0%
Q3 2018$6,428,000
+243.9%
122,918
+185.9%
0.00%
+300.0%
Q2 2018$1,869,000
+74.5%
43,000
+48.8%
0.00%0.0%
Q1 2018$1,071,000
+269.3%
28,900
+97.9%
0.00%
Q4 2017$290,000
-20.3%
14,6000.0%0.00%
Q3 2017$364,00014,6000.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
ALGERT GLOBAL LLC 68,100$980.01%
View complete list of G1 THERAPEUTICS INC shareholders